Highmark declares a war on opioids announcing the expansion of a Pennsylvania program. The idea is to give providers decision making support tools on pain management and opioid therapy.
The program is already in place in West Virginia and the numbers show patients receiving opioids from multiple subscribers has dropped 28%. Chief Medical Officer for Highmark, Charles Deshazer, says, “our industry must work with regulators, law enforcement, community leaders, and organizations to take meaningful steps… and we’re making a difference.”
The new policy is designed to help people who have never used opioids before reduce their risk of dependence.